Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$LFMD Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.16 down -166.67% YoY • Reported revenue of $47.28M down -24.01% YoY • LifeMD expects full year 2026 revenue of $205.5 million to $212.5 million and adjusted EBITDA of negative $6.0 million to breakeven, including launch costs for the XYOSTED auto-injector product.

Price since post

Full Details

Advertisement|Remove ads.